Share PriceASX CPH.AX: 0.32 (-0.04) AUD
Leveraging science and research, Creso Pharma will develop, register, and commercialise innovative therapeutic approaches that target the body’s endocannabinoid system.
Our pharmaceutical grade cannabis and hemp-based products will be developed to the highest GMP quality standards, and will be delivered with standardized dosing solutions and proprietary innovative delivery technologies enhancing bioavailability and absorption.
Creso Pharma’s therapeutic products aim to restore and maintain homeostasis for overall health & functioning of all bodily physiological processes for people and pets.
Subscribe to our alerts
The endocannabinoid system is possibly the single most important system within our entire bodies – responsible for maintaining homeostasis and regulating almost every aspect of our well being.
Creso Pharma’s products will supplement unbalanced, naturally occurring endocannabinoids with cannabinoids from the cannabis plant, naturally synergising the body’s endocannabinoid system.
Working to Good Manufacturing Practices (GMP) standards, Creso Pharma’s products will have wide ranging benefits in alleviating many symptoms of:
Our technologies will allow the standardisation of formulation and doses and increase absorption and bioavailability.